What stage does Aurora Science invest at?

Aurora Science invests at the Pre-Seed, Seed stages.

What sectors does Aurora Science focus on?

Aurora Science focuses on Biotech, Healthtech.

Where is Aurora Science located?

Aurora Science is headquartered in Milano, IT.

Aurora Science

Venture capital

Milano · Pre-Seed–Seed · 5 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

AurorA Science operates at the intersection of venture capital and translational medicine in the bio-pharma sector. It draws on the AurorA-TT team's operational and technology-transfer experience alongside the in-house R&D capabilities and drug development know-how of its strategic industrial partners, Rottapharm Biotech and Italfarmaco. This structure positions the firm to support the development and partnering of bio-pharma companies.

Invests inBiotech HealthtechEuropeItalyMilanMilano

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Seed

Milano, IT

Instruments

Equity

Founded

2014

Tracked investments

Team · 5 people

from the firm's website

Paolo Rizzardi· Co-Founder & Managing Partner

Physician and internist, co-founder and managing partner of AurorA-TT and co-founder, chairman and CEO of Altheia Science. He has extensive academic and biotech experience in cell and gene therapy and oncology, spanning R&D through market approval.

Pierluigi Paracchi· Co-Founder & Venture Consultant

Co-founder and venture consultant of AurorA-TT and co-founder of Altheia Science, with more than 15 years as a venture capitalist and biotech entrepreneur. He founded Quantica, was venture consultant at Sofinnova Partners, and is co-founder and CEO of Genenta Science.

Gabriele Campi· Immunologist / Technology Transfer

Immunologist with over a decade of academic research at San Raffaele Hospital and NYU, plus six-plus years in venture capital and technology transfer across Italy, Switzerland, and the UK, including work at TTFactor (IEO/IFOM).

Francesco De Santis· President, Italfarmaco Holding SpA

President of Italfarmaco Holding since 1995 and former Vice-President of Farmindustria, with roles across pharmaceutical industry bodies and scientific academic institutions.

Lucio Rovati· CEO & Chief Scientific Officer, Rottapharm Biotech· Milan

Physician specialized in clinical pharmacology with extensive clinical research experience across multiple therapeutic areas. He founded Rottapharm Biotech in 2014 and serves as its CEO and CSO, and is an invited professor of clinical pharmacology at the University of Milano-Bicocca.

What they invest in

from 1 of 2 portfolio companies

Biotech ×1Deep Tech ×1Healthtech ×1Medical Devices ×1

HQs:Spain×1

Investments · 2 tracked

founders shown can be your intro path

InteRNA

Dutch clinical-stage biotech developing proprietary RNA therapeutics targeting disease initiation and progression, with a focus on cancer.

Peptomycpeptomyc.comin 𝕏

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials.

BiotechDeep TechHealthtechMedical DevicesBarcelona, ES

Dr. Laura Soucek(Co-founder and CEO)Dr. Marie-Eve Beaulieu(Co-founder)Laura Soucek(Co-founder & CSO (former CEO))

Frequently asked questions

What stage does Aurora Science invest at?: Aurora Science invests at the Pre-Seed, Seed stages.
What sectors does Aurora Science focus on?: Aurora Science focuses on Biotech, Healthtech.
Where is Aurora Science located?: Aurora Science is headquartered in Milano, IT.

Images

Similar investors

8VC

8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.

$100K – $50M

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.

$50K – $12.7M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

Boundary Capital

Boundary Capital invests in high-growth private technology companies with the aim of positively impacting millions of lives, focusing on life sciences, AI, and engineering.

$190.5K – $635K

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M